Home

Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Maria Omsland defended Friday 03.02.2017 her dissertation «Investigation of the intercellular structure tunneling nanotube (TNT) in leukemia» at the University of Bergen.
Jan Roger Olsen defended January 27th 2017 his thesis ”Context dependent transcription factor regulation in normal and malignant cell differentiation” at the University of Bergen.
The Thon Foundation announced Thursday January 12th their allocations of funds for research. This year our faculty got two good reasons to celebrate. Professor Anne Berit Guttormsen at the Department of Clinical Medicine (K1) received an award for excellence in teaching, and CCBIO's Professor Lars A. Akslen and Postdoc Elisabeth Wik received support for the project "Harvard Cancer... Read more
The Norwegian Prime Minister Erna Solberg highlighted CCBIO PI James Lorens and his company BerGenBio in her New Year's Address as an example of excellent cancer research.
André Sulen defended 09.12.16 his PhD dissertation "Leukocyte p38 and p53 proteins after environmental exposure; variation, associations and applicability" at the University of Bergen.
This semester’s last CCBIO Junior Scientist Symposium took place December 8th. More than 40 researchers participated at the seminar where Professor Arild Raaheim from the Department of Education, University of Bergen, started the day with the lecture “Supervision. Challenges and possibilities”.
Close to a billion NOK is distributed through Fripro funding this year, among other to young researchers and as mobility grants. Cancer researcher and CCBIO postdoc Agnete Engelsen at the Department of Biomedicine is one of the supported young talents.
Cornelia Schuster defended 22.11.2016 her dissertation "Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab" at the University of Bergen.
Lavina Ahmed defended Wednesday November 2nd 2016 her dissertation «Axl as a Biomarker in Breast and Lung Cancer» at the University of Bergen.
Gøril Knutsvik defended Monday October 31st 2016 her thesis ”Biomarkers in breast cancer, with special focus on tumor cell proliferation” for the PhD degree at the University of Bergen.
Caroline Engen is a CCBIO PhD candidate who presented at the S.Net conference in Bergen. Her lecture was titled "Why Targeted Therapy May Not Work", and was part of the CCBIO session "The Transition from a Blockbuster Model to Personalised Cancer Therapy". We asked Caroline to walk us through a medical researcher's perspective of the conference and the use of new... Read more
CCBIO organized a special session with focus on the transition from a blockbuster to personalised cancer therapy at the S.Net conference recently held in Bergen.
11th October, CCBIO hosted a pre-conference event on the Ethical and Social Aspects of Cancer Research as part of the S.Net conference, of the Society for the Study of New and Emerging Technologies.
Medical research student (Forskerlinjestudent) Amalie A. Svanøe was awarded with 3rd best oral presentation at joint International Congress of the International Academy of Pathology and the European Congress of Pathology, which took place in Cologne, Germany, September 25-29, 2016.
September 14th, CCBIO, the Department of Clinical Science at UiB and the Women's Clinic at Helse Bergen organized a memorial symposium for Helga B. Salvesen, the CCBIO cancer researcher who passed away in January this year. People came from far and near to be together at this scientific gathering.
CCBIO Director Lars A. Akslen and CCBIO affiliated Arne Östman from Karolinska Institutet initiated and chaired The First Scandinavian Seminar on Translational Pathology. Approximately 50 cancer researchers gathered in the wild west of Sotra at Panorama Hotel outside of Bergen.
A new study suggests that reconstruction of breast affects recurrence of breast cancer, and actually reduce time to relapse of the disease. The study was recently presented as front page news in the journal Breast Cancer Research and Treatment, with main author Hanna Dillekås who is PhD candidate at Professor Oddbjørn Straumes group. Straume is CCBIO PI and also last author of the study.
A publication in PNAS by researchers from the Department of Clinical Science and CCBIO was selected to be highlighted in the Editors' Choice section of Science Signaling, the weekly journal from the publisher of Science magazine, and has been selected for an Editorial feature that will be published in the journal Cell Cycle.

Pages